Table of Contents 1 Study Coverage 1.1 Chronic Obstructive Pulmonary Disease Drugs Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Chronic Obstructive Pulmonary Disease Drugs Market Size Growth Rate by Product 1.4.2 Inhalers 1.4.3 Nebulizers 1.5 Market by End User 1.5.1 Global Chronic Obstructive Pulmonary Disease Drugs Market Size Growth Rate by End User 1.5.2 Emphysema 1.5.3 Chronic Bronchitis 1.5.4 Refractory Asthma 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Chronic Obstructive Pulmonary Disease Drugs Market Size 2.1.1 Global Chronic Obstructive Pulmonary Disease Drugs Revenue 2014-2025 2.1.2 Global Chronic Obstructive Pulmonary Disease Drugs Sales 2014-2025 2.2 Chronic Obstructive Pulmonary Disease Drugs Growth Rate by Regions 2.2.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales by Regions 2.2.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Chronic Obstructive Pulmonary Disease Drugs Sales by Manufacturers 3.1.1 Chronic Obstructive Pulmonary Disease Drugs Sales by Manufacturers 3.1.2 Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Manufacturers 3.1.3 Global Chronic Obstructive Pulmonary Disease Drugs Market Concentration Ratio (CR5 and HHI) 3.2 Chronic Obstructive Pulmonary Disease Drugs Revenue by Manufacturers 3.2.1 Chronic Obstructive Pulmonary Disease Drugs Revenue by Manufacturers (2014-2019) 3.2.2 Chronic Obstructive Pulmonary Disease Drugs Revenue Share by Manufacturers (2014-2019) 3.3 Chronic Obstructive Pulmonary Disease Drugs Price by Manufacturers 3.4 Chronic Obstructive Pulmonary Disease Drugs Manufacturing Base Distribution, Product Types 3.4.1 Chronic Obstructive Pulmonary Disease Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Chronic Obstructive Pulmonary Disease Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Chronic Obstructive Pulmonary Disease Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales by Product 4.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue by Product 4.3 Chronic Obstructive Pulmonary Disease Drugs Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Chronic Obstructive Pulmonary Disease Drugs Breakdown Data by End User 6 North America 6.1 North America Chronic Obstructive Pulmonary Disease Drugs by Countries 6.1.1 North America Chronic Obstructive Pulmonary Disease Drugs Sales by Countries 6.1.2 North America Chronic Obstructive Pulmonary Disease Drugs Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Chronic Obstructive Pulmonary Disease Drugs by Product 6.3 North America Chronic Obstructive Pulmonary Disease Drugs by End User 7 Europe 7.1 Europe Chronic Obstructive Pulmonary Disease Drugs by Countries 7.1.1 Europe Chronic Obstructive Pulmonary Disease Drugs Sales by Countries 7.1.2 Europe Chronic Obstructive Pulmonary Disease Drugs Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Chronic Obstructive Pulmonary Disease Drugs by Product 7.3 Europe Chronic Obstructive Pulmonary Disease Drugs by End User 8 Asia Pacific 8.1 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs by Countries 8.1.1 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Sales by Countries 8.1.2 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs by Product 8.3 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs by End User 9 Central & South America 9.1 Central & South America Chronic Obstructive Pulmonary Disease Drugs by Countries 9.1.1 Central & South America Chronic Obstructive Pulmonary Disease Drugs Sales by Countries 9.1.2 Central & South America Chronic Obstructive Pulmonary Disease Drugs Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Chronic Obstructive Pulmonary Disease Drugs by Product 9.3 Central & South America Chronic Obstructive Pulmonary Disease Drugs by End User 10 Middle East and Africa 10.1 Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs by Countries 10.1.1 Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Sales by Countries 10.1.2 Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs by Product 10.3 Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs by End User 11 Company Profiles 11.1 AstraZeneca 11.1.1 AstraZeneca Company Details 11.1.2 Company Business Overview 11.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2014-2019) 11.1.4 AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Products Offered 11.1.5 AstraZeneca Recent Development 11.2 Boehringer Ingelheim 11.2.1 Boehringer Ingelheim Company Details 11.2.2 Company Business Overview 11.2.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Products Offered 11.2.5 Boehringer Ingelheim Recent Development 11.3 GSK 11.3.1 GSK Company Details 11.3.2 Company Business Overview 11.3.3 GSK Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2014-2019) 11.3.4 GSK Chronic Obstructive Pulmonary Disease Drugs Products Offered 11.3.5 GSK Recent Development 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Company Business Overview 11.4.3 Novartis Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Novartis Chronic Obstructive Pulmonary Disease Drugs Products Offered 11.4.5 Novartis Recent Development 11.5 Teva Pharmaceuticals 11.5.1 Teva Pharmaceuticals Company Details 11.5.2 Company Business Overview 11.5.3 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Products Offered 11.5.5 Teva Pharmaceuticals Recent Development 11.6 Ache Laboratorios Farmaceuticos 11.6.1 Ache Laboratorios Farmaceuticos Company Details 11.6.2 Company Business Overview 11.6.3 Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Products Offered 11.6.5 Ache Laboratorios Farmaceuticos Recent Development 11.7 Almirall 11.7.1 Almirall Company Details 11.7.2 Company Business Overview 11.7.3 Almirall Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Almirall Chronic Obstructive Pulmonary Disease Drugs Products Offered 11.7.5 Almirall Recent Development 11.8 Aquinox Pharmaceuticals 11.8.1 Aquinox Pharmaceuticals Company Details 11.8.2 Company Business Overview 11.8.3 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Products Offered 11.8.5 Aquinox Pharmaceuticals Recent Development 11.9 Ario Pharma 11.9.1 Ario Pharma Company Details 11.9.2 Company Business Overview 11.9.3 Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Products Offered 11.9.5 Ario Pharma Recent Development 11.10 Asmacure 11.10.1 Asmacure Company Details 11.10.2 Company Business Overview 11.10.3 Asmacure Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Asmacure Chronic Obstructive Pulmonary Disease Drugs Products Offered 11.10.5 Asmacure Recent Development 11.11 Astellas Pharma 11.12 BioMarck Pharmaceuticals 12 Future Forecast 12.1 Chronic Obstructive Pulmonary Disease Drugs Market Forecast by Regions 12.1.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Regions 2019-2025 12.1.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue Forecast by Regions 2019-2025 12.2 Chronic Obstructive Pulmonary Disease Drugs Market Forecast by Product 12.2.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Product 2019-2025 12.2.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue Forecast by Product 2019-2025 12.3 Chronic Obstructive Pulmonary Disease Drugs Market Forecast by End User 12.4 North America Chronic Obstructive Pulmonary Disease Drugs Forecast 12.5 Europe Chronic Obstructive Pulmonary Disease Drugs Forecast 12.6 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Forecast 12.7 Central & South America Chronic Obstructive Pulmonary Disease Drugs Forecast 12.8 Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Chronic Obstructive Pulmonary Disease Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Chronic Obstructive Pulmonary Disease Drugs Product Picture Table Chronic Obstructive Pulmonary Disease Drugs Market Segments Table Key Manufacturers Chronic Obstructive Pulmonary Disease Drugs Covered Table Global Chronic Obstructive Pulmonary Disease Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Product 2014-2025 Figure Inhalers Product Picture Table Major Manufacturers of Inhalers Figure Nebulizers Product Picture Table Major Manufacturers of Nebulizers Table Global Chronic Obstructive Pulmonary Disease Drugs Market Size Growth Rate by End User 2019-2025 (K Units) Figure Emphysema Figure Chronic Bronchitis Figure Refractory Asthma Figure Others Figure Chronic Obstructive Pulmonary Disease Drugs Report Years Considered Figure Global Chronic Obstructive Pulmonary Disease Drugs Market Size 2014-2025 (Million US$) Figure Global Chronic Obstructive Pulmonary Disease Drugs Sales 2014-2025 (K Units) Table Global Chronic Obstructive Pulmonary Disease Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Chronic Obstructive Pulmonary Disease Drugs Sales by Regions 2014-2019 (K Units) Table Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Regions 2014-2019 Figure Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Regions 2014-2019 Figure 2018 Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Regions Table Global Chronic Obstructive Pulmonary Disease Drugs Revenue by Regions 2014-2019 (Million US$) Table Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Regions 2014-2019 Figure Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Regions 2014-2019 Figure 2018 Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Regions Table Global Chronic Obstructive Pulmonary Disease Drugs Sales by Manufacturers (2014-2019) (K Units) Table Global Chronic Obstructive Pulmonary Disease Drugs Sales Share by Manufacturers (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease Drugs Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Chronic Obstructive Pulmonary Disease Drugs Revenue by Manufacturers (2014-2019) (Million USD) Table Chronic Obstructive Pulmonary Disease Drugs Revenue Share by Manufacturers (2014-2019) Figure Chronic Obstructive Pulmonary Disease Drugs Value Share by Manufacturers in 2018 Table Key Manufacturers Chronic Obstructive Pulmonary Disease Drugs Price (2014-2019) (USD/Unit) Table Chronic Obstructive Pulmonary Disease Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Chronic Obstructive Pulmonary Disease Drugs Product Type Table Date of International Manufacturers Enter into Chronic Obstructive Pulmonary Disease Drugs Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Chronic Obstructive Pulmonary Disease Drugs Sales by Product (2014-2019) (K Units) Table Global Chronic Obstructive Pulmonary Disease Drugs Sales Share by Product (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Product (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Product in 2018 Table Global Chronic Obstructive Pulmonary Disease Drugs Revenue by Product (2014-2019) (Million US$) Table Global Chronic Obstructive Pulmonary Disease Drugs Revenue Share by Product (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Product (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Product in 2018 Table Chronic Obstructive Pulmonary Disease Drugs Price by Product 2014-2019 (USD/Unit) Table Global Chronic Obstructive Pulmonary Disease Drugs Sales by End User (2014-2019) (K Units) Table Global Chronic Obstructive Pulmonary Disease Drugs Sales Share by End User (2014-2019) Figure Global Sales Chronic Obstructive Pulmonary Disease Drugs Market Share by End User (2014-2019) Figure Global Sales Chronic Obstructive Pulmonary Disease Drugs Market Share by End User in 2018 Figure North America Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate 2014-2019 (K Units) Figure North America Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate 2014-2019 (Million US$) Table North America Chronic Obstructive Pulmonary Disease Drugs Sales by Countries (2014-2019) (K Units) Table North America Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries (2014-2019) Figure 2018 North America Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries Table North America Chronic Obstructive Pulmonary Disease Drugs Revenue by Countries (2014-2019) (Million US$) Table North America Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 North America Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries Figure United States Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure United States Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (K Units) Figure Canada Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Canada Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Mexico Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Table North America Chronic Obstructive Pulmonary Disease Drugs Sales by Product (2014-2019) (K Units) Table North America Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Product (2014-2019) Figure 2018 North America Chronic Obstructive Pulmonary Disease Drugs Market Share by Product Table North America Chronic Obstructive Pulmonary Disease Drugs Sales by End User (2014-2019) (K Units) Table North America Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by End User (2014-2019) Figure 2018 North America Chronic Obstructive Pulmonary Disease Drugs Market Share by End User Figure Europe Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate 2014-2019 (K Units) Figure Europe Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Europe Chronic Obstructive Pulmonary Disease Drugs Sales by Countries (2014-2019) (K Units) Table Europe Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Europe Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries Table Europe Chronic Obstructive Pulmonary Disease Drugs Revenue by Countries (2014-2019) (Million US$) Table Europe Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries Figure Germany Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Germany Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure France Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure France Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure UK Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure UK Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Italy Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Russia Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Europe Chronic Obstructive Pulmonary Disease Drugs Sales by Product (2014-2019) (K Units) Table Europe Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Product (2014-2019) Figure 2018 Europe Chronic Obstructive Pulmonary Disease Drugs Market Share by Product Table Europe Chronic Obstructive Pulmonary Disease Drugs Sales by End User (2014-2019) (K Units) Table Europe Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by End User (2014-2019) Figure 2018 Europe Chronic Obstructive Pulmonary Disease Drugs Market Share by End User Figure Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Sales by Countries (2014-2019) (K Units) Table Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries Table Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries Figure China Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure China Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Japan Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Korea Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure India Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure India Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Australia Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Philippines Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Thailand Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Singapore Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Sales by Product (2014-2019) (K Units) Table Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Market Share by Product Table Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Sales by End User (2014-2019) (K Units) Table Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Market Share by End User Figure Central & South America Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Chronic Obstructive Pulmonary Disease Drugs Sales by Countries (2014-2019) (K Units) Table Central & South America Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries Table Central & South America Chronic Obstructive Pulmonary Disease Drugs Revenue by Countries (2014-2019) (Million US$) Table Central & South America Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries Figure Brazil Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Brazil Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Argentina Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Chronic Obstructive Pulmonary Disease Drugs Sales by Product (2014-2019) (K Units) Table Central & South America Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Chronic Obstructive Pulmonary Disease Drugs Market Share by Product Table Central & South America Chronic Obstructive Pulmonary Disease Drugs Sales by End User (2014-2019) (K Units) Table Central & South America Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Chronic Obstructive Pulmonary Disease Drugs Market Share by End User Figure Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Sales by Countries (2014-2019) (K Units) Table Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Countries Table Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Countries Figure GCC Countries Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Turkey Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure Egypt Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate (2014-2019) (K Units) Figure South Africa Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Sales by Product (2014-2019) (K Units) Table Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Market Share by Product Table Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Sales by End User (2014-2019) (K Units) Table Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Market Share by End User Table AstraZeneca Company Details Table AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table AstraZeneca Recent Development Table Boehringer Ingelheim Company Details Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Boehringer Ingelheim Recent Development Table GSK Company Details Table GSK Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table GSK Recent Development Table Novartis Company Details Table Novartis Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Recent Development Table Teva Pharmaceuticals Company Details Table Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Teva Pharmaceuticals Recent Development Table Ache Laboratorios Farmaceuticos Company Details Table Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Ache Laboratorios Farmaceuticos Recent Development Table Almirall Company Details Table Almirall Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Almirall Recent Development Table Aquinox Pharmaceuticals Company Details Table Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Aquinox Pharmaceuticals Recent Development Table Ario Pharma Company Details Table Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Ario Pharma Recent Development Table Asmacure Company Details Table Asmacure Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Asmacure Recent Development Table Astellas Pharma Company Details Table BioMarck Pharmaceuticals Company Details Table Global Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Regions 2019-2025 (K Units) Table Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share Forecast by Regions 2019-2025 Table Global Chronic Obstructive Pulmonary Disease Drugs Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share Forecast by Regions 2019-2025 Table Global Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Product 2019-2025 (K Units) Table Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share Forecast by Product 2019-2025 Table Global Chronic Obstructive Pulmonary Disease Drugs Revenue Forecast by Product 2019-2025 (Million US$) Table Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share Forecast by Product 2019-2025 Table Global Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by End User 2019-2025 (K Units) Table Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share Forecast by End User 2019-2025 Figure North America Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Chronic Obstructive Pulmonary Disease Drugs Value Chain Table Chronic Obstructive Pulmonary Disease Drugs Customers List Table Chronic Obstructive Pulmonary Disease Drugs Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

AstraZeneca Boehringer Ingelheim GSK Novartis Teva Pharmaceuticals Ache Laboratorios Farmaceuticos Almirall Aquinox Pharmaceuticals Ario Pharma Asmacure Astellas Pharma BioMarck Pharmaceuticals